Image Emosis

Diagnostics company dedicated to developing and commercializing high-performance in vitro diagnostic kits

Frederic Allemand
Co-fondateur
LinkedIn

Presentation

Development Stage of your Startup : Operating and Sales

Emosis is a French diagnostics company dedicated to developing and commercializing high-performance in vitro diagnostic kits that will quantify and differentiate between ranges of hemostasis disorders which can be either disease-related or drug-induced. The full range of Emosis IVD kits will enable in-hospital laboratories to quickly and routinely test for and assess hemostasis disorders so that patients can immediately receive optimal treatment based on an accurate diagnosis. Our new diagnostic system will significantly improve the care of millions of affected patients worldwide every year. Emosis first diagnostic kit is due for European launch in 2017. It will be used to confirm the diagnosis of Heparin-Induced Thrombocytopenia (HIT). HIT is a rare, but life-threatening, disorder that is frequently suspected in hospital in-patients treated with heparin.

Market

Medtech, diagnostics

Main customers

In-hospital laboratories

Problem / Customers

Diagnostics company dedicated to developing and commercializing high-performance in vitro diagnostic kits that will quantify and differentiate between ranges of hemostasis disorders